Foxp3+ Regulatory T Cells Promote T Helper 17 Cell Development In Vivo through Regulation of Interleukin-2

被引:132
作者
Chen, Yi [1 ]
Haines, Christopher J. [1 ]
Gutcher, Ilona [2 ]
Hochweller, Kristin [3 ]
Blumenschein, Wendy M. [1 ]
McClanahan, Terrill [1 ]
Haemmerling, Guenter [3 ]
Li, Ming O. [2 ]
Cua, Daniel J. [1 ]
McGeachy, Mandy J. [1 ]
机构
[1] Merck Res Labs, Palo Alto, CA 94304 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
[3] German Canc Res Ctr, Div Mol Immunol, D-69120 Heidelberg, Germany
关键词
TGF-BETA; TH17; CELLS; IFN-GAMMA; DIFFERENTIATION; INDUCTION; T(H)17; IL-2; INFLAMMATION; HOMEOSTASIS; EXPRESSION;
D O I
10.1016/j.immuni.2011.02.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T helper 17 (Th17) cell development is driven by cytokines including transforming growth factor-beta (TGF-beta), interleukin-6 (IL-6), IL-1, and IL-23. Regulatory T (Treg) cells can provide the TGF-beta in vitro, but their role in vivo remains unclear, particularly because Treg Th17 cell-associated autoimmunity. We used mice expressing Diphtheria toxin receptor under control of the Foxp3 promoter to deplete Foxp3(+) Treg cells in adult mice during in vivo Th17 cell priming. Treg cell depletion resulted in a reduced frequency of antigen-specific IL-17 producers in draining lymph nodes and blood, correlating with reduced inflammatory skin responses. In contrast, Treg cells did not promote IL-17 secretion after initial activation stages. Treg cell production of TGF-beta was not required for Th17 cell promotion, and neither was suppression of Th1 cell-associated cytokines. Rather, regulation of IL-2 availability and resultant signaling through CD25 by Treg cells was found to play an important role.
引用
收藏
页码:409 / 421
页数:13
相关论文
共 41 条
[1]   CD25+CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production [J].
Barthlott, T ;
Moncrieffe, H ;
Veldhoen, M ;
Atkins, CJ ;
Christensen, J ;
O'Garra, A ;
Stockinger, B .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (03) :279-288
[2]   Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice [J].
Bending, David ;
De La Pena, Hugo ;
Veldhoen, Marc ;
Phillips, Jenny M. ;
Uyttenhove, Catherine ;
Stockinger, Brigitta ;
Cooke, Anne .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (03) :565-572
[3]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[4]   From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited [J].
Boniface, Katia ;
Blom, Bianca ;
Liu, Yong-Jun ;
Malefyt, Rene de Waal .
IMMUNOLOGICAL REVIEWS, 2008, 226 :132-146
[5]   Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation [J].
Das, Jyoti ;
Ren, Guangwen ;
Zhang, Liying ;
Roberts, Arthur I. ;
Zhao, Xin ;
Bothwell, Alfred L. M. ;
Van Kaer, Luc ;
Shi, Yufang ;
Das, Gobardhan .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (11) :2407-2416
[6]   Interleukin-2 is essential for CD4+CD25+ regulatory T cell function [J].
de la Rosa, M ;
Rutz, S ;
Dorninger, H ;
Scheffold, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (09) :2480-2488
[7]   T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells [J].
Fahlén, L ;
Read, S ;
Gorelik, L ;
Hurst, SD ;
Coffman, RL ;
Flavell, RA ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) :737-746
[8]   Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003) [J].
Fontenot, Jason D. ;
Gavin, Marc A. ;
Rudensky, Alexander Y. .
JOURNAL OF IMMUNOLOGY, 2017, 198 (03) :986-992
[9]   Interleukin 2 signaling is required for CD4+ regulatory T cell function [J].
Furtado, GC ;
de Lafaille, MAC ;
Kutchukhidze, N ;
Lafaille, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :851-857
[10]   Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo [J].
Gavin, MA ;
Clarke, SR ;
Negrou, E ;
Gallegos, A ;
Rudensky, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :33-41